Switch theme
Sign up to access all valuation multiples
Aplisens SA is engaged in manufacturing of measuring instruments. It focuses on electronic pressure and differential pressure measurement technology. The company's products include differential pressure transmitters, hydrostatic level probes, level transmitters, valves, digital indicators and power supplies.
1992
489
LTM Revenue $40.6M
LTM EBITDA $9.3M
$45.8M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Aplisens has a last 12-month revenue of $40.6M and a last 12-month EBITDA of $9.3M.
In the most recent fiscal year, Aplisens achieved revenue of $41.9M and an EBITDA of $12.3M.
Aplisens expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Aplisens valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $38.0M | $41.9M | XXX | XXX | XXX |
| Gross Profit | $11.2M | $15.1M | XXX | XXX | XXX |
| Gross Margin | 30% | 36% | XXX | XXX | XXX |
| EBITDA | $8.5M | $12.3M | XXX | XXX | XXX |
| EBITDA Margin | 22% | 29% | XXX | XXX | XXX |
| Net Profit | $4.4M | $5.2M | XXX | XXX | XXX |
| Net Margin | 12% | 13% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Aplisens's stock price is PLN 19 (or $5).
Aplisens has current market cap of PLN 206M (or $52.9M), and EV of PLN 178M (or $45.8M).
See Aplisens trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $45.8M | $52.9M | XXX | XXX | XXX | XXX | $0.50 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Aplisens has market cap of $52.9M and EV of $45.8M.
Aplisens's trades at 1.1x LTM EV/Revenue multiple, and 4.9x LTM EBITDA.
Analysts estimate Aplisens's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Aplisens and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $45.8M | XXX | XXX | XXX |
| EV/Revenue | 1.1x | XXX | XXX | XXX |
| EV/EBITDA | 3.7x | XXX | XXX | XXX |
| P/E | 6.5x | XXX | XXX | XXX |
| P/E/Growth | -0.8x | XXX | XXX | XXX |
| EV/FCF | 8.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpAplisens's NTM/LTM revenue growth is 6%
Aplisens's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $14K for the same period.
Over next 12 months, Aplisens's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Aplisens's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Aplisens and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 10% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 29% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 45% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 36% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.1M | XXX | XXX | XXX | XXX |
| Opex per Employee | $14K | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 4% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 13% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 17% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Catapult | XXX | XXX | XXX | XXX | XXX | XXX |
| Optiscan Imaging | XXX | XXX | XXX | XXX | XXX | XXX |
| NanoFocus | XXX | XXX | XXX | XXX | XXX | XXX |
| Jenoptik | XXX | XXX | XXX | XXX | XXX | XXX |
| Knorr-Bremse | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Aplisens acquired XXX companies to date.
Last acquisition by Aplisens was XXXXXXXX, XXXXX XXXXX XXXXXX . Aplisens acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Aplisens founded? | Aplisens was founded in 1992. |
| Where is Aplisens headquartered? | Aplisens is headquartered in Poland. |
| How many employees does Aplisens have? | As of today, Aplisens has 489 employees. |
| Is Aplisens publicy listed? | Yes, Aplisens is a public company listed on WAR. |
| What is the stock symbol of Aplisens? | Aplisens trades under APN ticker. |
| When did Aplisens go public? | Aplisens went public in 2009. |
| Who are competitors of Aplisens? | Similar companies to Aplisens include e.g. Catapult, Optiscan Imaging, NanoFocus, Jenoptik. |
| What is the current market cap of Aplisens? | Aplisens's current market cap is $52.9M |
| What is the current revenue of Aplisens? | Aplisens's last 12-month revenue is $40.6M. |
| What is the current EBITDA of Aplisens? | Aplisens's last 12-month EBITDA is $9.3M. |
| What is the current EV/Revenue multiple of Aplisens? | Current revenue multiple of Aplisens is 1.1x. |
| What is the current EV/EBITDA multiple of Aplisens? | Current EBITDA multiple of Aplisens is 4.9x. |
| What is the current revenue growth of Aplisens? | Aplisens revenue growth between 2023 and 2024 was 10%. |
| Is Aplisens profitable? | Yes, Aplisens is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
